About This Journal:

  • Print This Page
  • Subscribe to an RSS Feed

Sample Content 

My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Human Gene Therapy

Editor-in-Chief: Terence R. Flotte, MD
Deputy Editors, Europe: Nathalie Cartier, MD and Thierry VandenDriessche, PhD
Deputy Editors, U.S.: Barry J. Byrne, MD, PhD and Mark A. Kay, MD, PhD
Human Gene Therapy Editor: Guangping Gao, PhD
Methods Editor: Hildegard Büning, PhD
Clinical Development Editor: James M. Wilson, MD, PhD

ISSN: 1043-0342 • Online ISSN: 1557-7422 • Published 22 issues annually

Current Volume: 28

Latest Impact Factor* is 4.062

*2015 Journal Citation Reports® published by Thomson Reuters, 2016


“Gene therapy has moved into the mainstream of translational and clinical research. The time is optimal to begin to document the methods used in gene therapy so investigators can apply the successful laboratory approaches to expand the application of gene transfer to the treatment and prevention of disease. HGT Methods is important contribution the field.”

Ronald G. Crystal
Weill Medical College of Cornell University


“The full impact of gene therapy on human disease will be greatly accelerated if the latest methods can be disseminated rapidly and broadly to those interested in specific human disease models. The introduction of HGT Methods fulfills that need in unique way that is not currently being served by any other journal in the field.”

Terence Flotte
University of Massachusetts Medical School


HGT was the original gene therapy journal and continues to lead the field. The expansion of HGT Methods provides a complementary authoritative vehicle for dissemination of novel methods and significant improvements to existing clinical, translational and research technologies. HGT and HGT Methods…provide essential insights and new tools to advance the field.”

Professor J. George Dickson
University of London

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Tissue Engineering, Parts A, B, & C

    Tissue Engineering, Parts A, B, & C

    The preeminent, biomedical journal bringing together the principles of engineering and life sciences to advance the field with cutting-edge research and applications on all aspects of tissue growth and regeneration.

    Nucleic Acid Therapeutics

    Nucleic Acid Therapeutics

    formerly Oligonucleotides

    Focuses on cutting-edge research and applications to find and examine new approaches using nucleic acids in therapeutics including oligonucleotides, gene modification, aptamers, RNA nanoparticles, ribozymes, and more.

    Stem Cells and Development

    Stem Cells and Development

    Globally recognized as the trusted source for critical, even controversial coverage of emerging hypotheses and novel findings on stem cells of all tissue types and their potential therapeutic applications.



    Solely focused on disseminating the latest cutting-edge advances in the zebrafish as a model organism for the study of vertebrate development, with attention to other aquarium species including medaka, Fugu, and Xiphophorus.

Browse All Publications »